CrushSCI.com
149.4Average days
120.5Median days
26Fastest days
573Longest days
1832025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

181 days

Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes

Authors
Pu Wang; Xinchang Liu; Yong Xie; Yingjun Zhang; Baohua Gu; Jing Li; Yunfu ChenShow moreShow less
Affiliations
Sunshine Lake Pharma Co., Ltd., Dongguan, PR China; State Key Laboratory of Anti-Infective Drug Discovery and Development, Dongguan, PR China; Enterprise Key Laboratory of Anti-viral Drug Development for Guangdong Province, Dongguan, PR ChinaShow moreShow less
Source PDF DOI Publisher page
74 days

Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing

Authors
Hiteshi Vaidya; Manoj KumarShow moreShow less
Affiliations
Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39A, Chandigarh, 160036, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, Punjab, 160062, IndiaShow moreShow less
Source PDF DOI Publisher page
115 days

Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation

Authors
Fan Pu; Yiwan Guo; Xinni Pan; Xin Liu; Fan YangShow moreShow less
Affiliations
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, China; Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022, China; Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, China; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, ChinaShow moreShow less
Source PDF DOI Publisher page
110 days

HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearance

Authors
Bai-Hua Zhang; Yuanping Zhou; Yukun Wu; Stephen Horrigan; Laura Luckenbaugh; Jianming Hu; Fabien Zoulim; Yong-Yuan ZhangShow moreShow less
Affiliations
Virology, HBVtech, Rockville, MD, USA; Department of Infectious Diseases & Gastroenterology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China; The YW Statistical Consulting, Ellicott City, MD, USA; Preclinical Department, Noble Life Sciences, Sykesville, MD, USA; Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, USA; UMR PaThLiv U1350, INSERM, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Lyon Hepatology Institute, IHU EVEREST, Lyon, FranceShow moreShow less
Source PDF DOI Publisher page
137 days

Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor

Authors
Jintao Zou; Lingyu Su; Jiansheng Lu; Haiming Jing; Jiahang Liu; Xiaoqiang Zeng; Menghan Ma; De Zhao; Jun Zhang; Zhang Zhang; Jinyong Zhang; Xiaopeng ZhangShow moreShow less
Affiliations
National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing, 100071, China; Nanhu Laboratory, Jiaxing, Zhejiang, 314050, China; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, 400038, ChinaShow moreShow less
Source PDF DOI Publisher page
26 days

Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium

Authors
Yannick Debing; Hannah Vanrusselt; Cheng Liu; Jordi Verheyen; Lars Degrauwe; Dieudonné Buh Kum; Abel Acosta Sanchez; Adilson Carlos Francisco; Emma Wanicek; Hans J. Netter; Paul A. Ramsland; Andrew Leis; Shabih Shakeel; Jerome Deval; Michael Welch; Vladimir Serebryany; Antitsa Stoycheva; Leonid Beigelman; Pierre Raboisson; Sandrine Vendeville; Tse-I Lin; Lawrence M. Blatt; David B. Smith; Julian A. Symons; Lauriane Lecoq; Andreas JekleShow moreShow less
Affiliations
Aligos Belgium BV, Leuven, Belgium; Aligos Therapeutics, Inc., South San Francisco, United States; Novalix, Leuven, Belgium; Molecular Microbiology and Structural Biochemistry (MMSB), UMR 5086 CNRS, Université de Lyon, France; School of Science, STEM College, RMIT University, Bundoora, Victoria, Australia; Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, VIC, 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3052, Australia; ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Bio21 Molecular Science and 9 Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, VIC, 3052, AustraliaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.